Reflecting on our strategic directions to provide comprehensive pathway for the diagnosis, treatment and management of Peripheral arterial diseases, diabetic wounds and Cardiovascular diseases, we have successfully signed an agreement with First Kind, a UK manufacturer, which produces the world’s only Neuromuscular Electrostimulation device, with a ground breaking technology. The device’s objective is to provide circulatory support for the lower extremities eliminating the risk for Venous Thromboembolism (VTE), preventing and resolving odema and accelerating wound healing.